Abstract

Objective: Human metapneumovirus (hMPV), particularly affecting children under five, is a significant viral agent associated with a wide range of respiratory illnesses, from mild upper respiratory infections to severe lower respiratory tract involvement. This study aimed to evaluate the clinical characteristics, severity indicators, and seasonal distribution of hMPV infections over a four-year period in one of Türkiye’s largest pediatric hospitals, and to assess the potential epidemic risk in the national context.

Material and Methods: This retrospective study included 345 pediatric patients diagnosed with hMPV between January 2021 and December 2024. Demographic data, clinical findings, hospitalization status, respiratory support requirements, imaging results, and outcomes were analyzed.

Results: The median age was four years; 44.6% of patients were hospitalized, and 9.2% required intensive care. Common symptoms included cough (84.1%), fever (65.8%), and rhinorrhea (59.7%). Hypoxia, tachypnea, and pulmonary infiltrates were significantly associated with hospitalization (p<0.001). Four patients died, three without known comorbidities. The highest case count occurred in 2022, followed by a marked decline in 2023–2024, consistent with global trends.

Conclusion: Although generally considered mild, hMPV infection can result in severe disease and mortality, even in healthy children. These findings highlight the importance of early risk identification and integration of hMPV into respiratory infection surveillance and public health strategies. No significant outbreak was observed in Türkiye during the study period.

Keywords: Children, human metapneumovirus, respiratory tract infections, respiratory viruses

References

  1. Mishra B, Mohapatra D, Tripathy M, Mamidi P, Mohapatra PR. A Re-emerging Respiratory Virus: Human Metapneumovirus (hMPV). Cureus. 2025;17(2):e78354.https://doi.org/10.7759/cureus.78354
  2. Ebihara T, Endo R, Kikuta H, Ishiguro N, Ishiko H, Kobayashi K. Comparison of the Seroprevalence of Human Metapneumovirus and Human Respiratory Syncytial Virus. J Med Virol. 2004;72(2):304-6.https://doi.org/10.1002/jmv.10572
  3. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children. N Engl J Med. 2015;372(9):835. https://doi.org/10.1056/NEJMoa1405870
  4. Mishra P, Nayak L, Das RR, Dwibedi B, Singh A. Viral Agents Causing Acute Respiratory Infections in Children under Five: A Study from Eastern India. Int J Pediatr. 2016;2016:7235482. https://doi.org/10.1155/2016/7235482
  5. Al-Tawfiq JA, Memish ZA. The surge of human metapneumovirus (hMPV) cases in China and global implications. New Microbes New Infect. 2025;63:101563. https://doi.org/10.1016/j.nmni.2025.101563
  6. Ji W, Chen Y, Han S, Dai B, Li K, Li S, et al. Clinical and epidemiological characteristics of 96 pediatric human metapneumovirus infections in Henan, China after COVID-19 pandemic: a retrospective analysis. Virol J . 2024 Dec 1;21(1):100. https://doi.org/10.1186/s12985-024-02376-0
  7. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children. N Engl J Med. 2015;372(9):835. https://doi.org/10.1056/NEJMoa1405870
  8. Liu T, Li Z, Zhang S, Song S, Julong W, Lin Y, et al. Viral Etiology of acute respiratory tract infections in hospitalized children and adults in Shandong Province, China. Virol J. 2015;12(1):168. https://doi.org/10.1186/s12985-015-0388-z
  9. Wang X, Li Y, Deloria-Knoll M, Madhi SA, Cohen C, Ali A, et al. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020;9(1):e33
  10. Edwards KM, Zhu Y, Griffin MR, Weinberg GA, Hall CB, Szilagyi PG, et al. Burden of Human Metapneumovirus Infection in Young Children. N Engl J Med. 2013;368(7):633. https://doi.org/10.1056/NEJMoa1204630
  11. Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191. https://doi.org/10.1016/S1473-3099(18)30310-4
  12. McAllister DA, Liu L, Shi T, Chu Y, Reed C, Burrows J, et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. 2018;7(1):e47. https://doi.org/10.1016/S2214-109X(18)30408-X
  13. McAdam AJ, Hasenbein ME, Feldman HA, Cole SE, Offermamn JT, Riley AM, et al. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004;190(1):20-6. https://doi.org/10.1086/421120
  14. Peret TCT, Boivin G, Li Y, Couillard M, Humphrey C, Osterhaus ADME, et al. Characterization of Human Metapneumoviruses Isolated from Patients in North America. J Infect Dis. 2002;185(11):1660. https://doi.org/10.1086/340518
  15. Wilkesmann A, Schildgen O, Eis-Hübinger AM, Geikowski T, Glatzel T, Lentze MJ, et al. Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr. 2006;165(7):467-75. https://doi.org/10.1007/s00431-006-0105-4
  16. Howard LM, Edwards KM, Zhu Y, Grijalva CG, Self WH, Jain S, et al. Clinical Features of Human Metapneumovirus-Associated Community-acquired Pneumonia Hospitalizations. Clin Infect Dis. 2020;72(1):108. https://doi.org/10.1093/cid/ciaa088
  17. Otomaru H, Nguyen HAT, Vo HM, Toizumi M, Le MN, Mizuta K, et al. A decade of human metapneumovirus in hospitalized children with acute respiratory infection: molecular epidemiology in central Vietnam, 2007-2017. Sci Rep. 2023;13(1):15757. https://doi.org/10.1038/s41598-023-42692-z
  18. Zhao H, Feng Q, Feng Z, Zhu Y, Ai J, Xu B, et al. Clinical characteristics and molecular epidemiology of human metapneumovirus in children with acute lower respiratory tract infections in China, 2017 to 2019: A multicentre prospective observational study. Virol Sin. 2022;37(6):874. https://doi.org/10.1016/j.virs.2022.08.007
  19. Veronese A, Uršič T, Bizjak Vojinovič S, Rodman Berlot J. Exploring Clinical Predictors of Severe Human Metapneumovirus Respiratory Tract Infections in Children: Insights from a Recent Outbreak. Microorganisms. 2024;12(4):641.https://doi.org/10.3390/microorganisms12040641
  20. Philippot Q, Rammaert B, Dauriat G, Daubin C, Schlemmer F, Costantini A, et al. Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients. Heliyon. 2024;10(13):e33231. https://doi.org/10.1016/j.heliyon.2024.e33231
  21. Esper F, Boucher D, Weibel C, Martinello RA, Kahn JS. Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics. 2003;111(6 Pt 1):1407-10. https://doi.org/10.1542/peds.111.6.1407
  22. Kivit CMHJ, Groen K, Jongbloed M, Linssen CFM, van Loo A, van Gorp ECM, et al. An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown. J Infect. 2022;84(5):722. https://doi.org/10.1016/j.jinf.2022.01.042
  23. Trends of acute respiratory infection, including human metapneumovirus, in the Northern Hemisphere [Internet].[cited 2025 Apr 4]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON550

How to cite

1.
Kalaycı F, Aslinur Özkaya Parlakay A, Çırak A, Karaköse E, Çelebier K, Yiğit M. Retrospective analysis of human metapneumovirus in hospitalized and outpatient children: Insights from a four-year experience in Türkiye. Turk J Pediatr Dis [Internet]. 2025 Jul. 31 [cited 2025 Aug. 23];. Available from: https://turkjpediatrdis.org/article/view/1167